Results 171 to 180 of about 121,575 (281)

Global and Regional Patterns of Drug Resistance and Treatment Regimens in Spinal Tuberculosis: A Systematic Review and Meta-Analysis. [PDF]

Global Spine J
Rajasekaran S, Gurusamy G, Shetty AP, Kanna RM, Bicholkar AU, Sathwik N, Bindu Vasanthi N, Gogul SP, Gandhi AP, Vv G, Kaviprawin M.   +10 more
europepmc   +1 more source

Molecular Diagnostics for WHO Priority Bacterial Pathogens: A Bibliometric Mapping of Diagnostic Platforms, Resistance Markers, and Antimicrobial Resistance Research Trends

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
This bibliometric mapping of 1746 publications (2000–2025) charts molecular diagnostics for WHO priority bacterial pathogens across platforms, targets, and resistance markers. Conventional PCR/NAAT and whole‐genome sequencing emerge as complementary core platforms, and the field evolves from targeted pathogen detection into an AMR‐centered ...
Selahattin Ünlü
wiley   +1 more source

Submerged Spark Plasma Discharges for the Removal of Antibiotics, Antibiotic-Resistant Bacteria, and Resistance Genes. [PDF]

Plasma Chem Plasma Process
He J, Fridman G, Bailey C, Rabinovich A, Fridman A, Sales CM.   +5 more
europepmc   +1 more source

Genetic Diversity and Epidemiological Overlap of Staphylococcus aureus at the Animal–Food–Environment–Human Interface Within a One Health Framework

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
Integrating farm‐to‐fork and clinical surveillance, this study reveals distinct SCCmec distributions alongside shared spa types across human, animal, and food interfaces. The results of genetic diversity and epidemiological overlap underscore the critical need for coordinated One Health surveillance to monitor multi‐sectoral Staphylococcus aureus ...
Pinar Sagiroglu, Dursun Alp Gundog, Candan Gungor, Kursat Koskeroglu, Mustafa Altay Atalay, Adalet Dishan, Yeliz Ucar, Aytac Akcay, Huseyin Burak Disli, Harun Hizlisoy, Mukaddes Barel, Tekin Kececi, Nurhan Ertas Onmaz   +12 more
wiley   +1 more source

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment. [PDF]

J Antimicrob Chemother
Beca LSDAB, Mumbiro V, Bwakura M, Mujuru HA, Mudzingwa S, Tagarro A, Domínguez-Rodríguez S, Musiime V, Nalwanga D, Buck WC, Sacarlal J, Chabala C, Chansa BN, Rojo P, Burger DM, Moraleda C, Jacobs TG, EMPIRICAL Clinical Trial Group.   +17 more
europepmc   +1 more source

A Novel Nanoantibiotic Formulation With Magnetic and Targeting Potential: Ampicillin‐Conjugated L‐glu–Fe3O4 NPs

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
A novel nanoformulation consisting of ampicillin (Amp), l‐glutamic acid (l‐glu), and iron oxide nanoparticles was prepared. l‐glu–Fe3O4–Amp NPs exhibited a controlled drug release profile over a certain period of time. The antibacterial effectiveness of the formulation was proven by agar well diffusion and the LIVE/DEAD BacLight fluorescent assays. The
Mehmet Demirel, Ozlem Baris, Mesut Taskin, Seyda Albayrak, Ferhunde Aysin, Azada Aliyeva, Buket Bakan   +6 more
wiley   +1 more source

[Antimicrobial therapy of periprosthetic joint infection : Summary of AE guidelines (2026)]. [PDF]

Orthopadie (Heidelb)
Feihl S, Meller S, Gramlich Y, von Eisenhart-Rothe R, Hube R, Radünzel P, Otchwemah R, Hischebeth G.   +7 more
europepmc   +1 more source

Post‐Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management

MedComm, Volume 7, Issue 10, October 2026.
A comprehensive review on post‐tuberculosis lung disease (PTLD) addresses the epidemiology, pathogenesis, clinical phenotypes and management, risk factors, prevention and systems approach, and future directions. This review provides standardized definitions, mechanistic insights and biomarkers of PTLD development, and clinical strategies for PTLD ...
Radha Gopalaswamy, Selvakumar Subbian
wiley   +1 more source

Functional Brain Imaging Reveals Reconstitution of the Central Nervous Itch Network Upon Rifampicin Therapy in Hepatic Pruritus

Acta Dermato-Venereologica
Marcel Vetter, Theresa Buchwald, Arnd Dörfler, Clemens Forster, Andreas E. Kremer   +4 more
doaj   +1 more source

Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci. [PDF]

Sci Rep
Karačić J, Karačić S, Grosse M, Schiefer A, Pfarr K, Schneider T, Schneider T, Hoerauf A, Bierbaum G.   +8 more
europepmc   +1 more source